How much did Balaji Amines' revenue grow in Q1 FY27?

Consolidated revenue rose 27% year-on-year to ₹455.9 crore, driven by strong demand in amines and specialty chemicals.

What drove the near-doubling of net profit?

Net profit jumped 97% to ₹74.9 crore as improved margins amplified the revenue gain. Standalone PBT nearly doubled to ₹97.8 crore.

Is the DME plant reflected in these results?

The Q1 FY27 results cover the period when the DME plant was commissioned. The profit surge likely includes early benefits, but full impact should be clearer in coming quarters.

How does this compare with the same quarter last year?

Revenue was ₹359 crore and net profit ₹38 crore in Q1 FY26. The 27% and 97% increases represent a sharp acceleration from the prior year.

Earnings · Chemicals · Mid cap

Balaji Amines net profit surges 97% in Q1 FY27

Revenue climbs 27% to ₹455.9 cr as improved margins in core amines drive a decisive quarter for the specialty chemicals maker.

— 1 earlier story on Balaji Amines Ltd. →

BALAMINES By Tipsheet Editorial 27 Jul 2026 · 6:28 PM IST Verify on BSE · NSE

Mkt cap₹6,445 cr

P/E38.54×

ROE8.46%

Debt / eq.0.07

Div yld0.53%

₹74.9 cr Net profit, up 97% YoY, nearly doubling

What's new

Consolidated revenue up 27% to ₹455.9 crore in Q1 FY27.
Net profit attributable to shareholders surged 97% to ₹74.9 crore.
Standalone PBT nearly doubled to ₹97.8 crore.

Why this matters

The 97% profit leap on a 27% revenue gain shows improved margins in Balaji's core amines business. With negligible debt (D/E 0.07) and a freshly commissioned DME plant, the earnings beat adds conviction to a turnaround story investors have been tracking.

What we're watching

Management commentary on demand sustainability post-agriculture season.
DME plant utilisation ramp-up and margin contribution.
Any guidance revision after the earnings call.

The full read

Balaji Amines delivered a quarter that turns the narrative. Revenue of ₹455.9 crore (up 27%) is solid, but net profit of ₹74.9 crore (up 97%) is the headline. The company runs with near-zero debt (D/E 0.07) and a fresh DME plant online, so improved margins flow straight to the bottom line. Standalone PBT nearly doubled to ₹97.8 crore. This isn't a one-off blip: it confirms a recovery six months in the making. Investors who held through the trough now get the payoff. The earnings call next will test whether management sees this as a sustainable run rate or a seasonal high.

Questions answered

How much did Balaji Amines' revenue grow in Q1 FY27?: Consolidated revenue rose 27% year-on-year to ₹455.9 crore, driven by strong demand in amines and specialty chemicals.
What drove the near-doubling of net profit?: Net profit jumped 97% to ₹74.9 crore as improved margins amplified the revenue gain. Standalone PBT nearly doubled to ₹97.8 crore.
Is the DME plant reflected in these results?: The Q1 FY27 results cover the period when the DME plant was commissioned. The profit surge likely includes early benefits, but full impact should be clearer in coming quarters.
How does this compare with the same quarter last year?: Revenue was ₹359 crore and net profit ₹38 crore in Q1 FY26. The 27% and 97% increases represent a sharp acceleration from the prior year.

Mentioned: Balaji Amines · DME plant · ₹455.9 cr revenue

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Balaji Amines Ltd.

Chemicals

₹7,394 cr

P/E 36.22×

Latest quarter · Jun 2026

Sales₹456 cr

Net profit₹78 cr

Op. margin+25.4%

EPS₹23.13

Strength & growth

Debt / equity0.07×

Current ratio2.34×

Sales CAGR+7.8%

EPS CAGR+8.1%

Story so far

All notes on BALAMINES →

27 Jul 2026 · 6:28 PM IST Balaji Amines net profit surges 97% in Q1 FY27
1d ago Balaji Amines doubles profit, commissions India's first DME plant